Besim Ogretmen

28PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersCell development, proliferation and deathApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Occupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 15, 2026
Tumor and Stromal Sphingolipid Imbalance Are Associated with T Cell Tissue Residency in Glioblastoma.

|Jul 06, 2026
Proteomic analysis of sphingolipid metabolic enzymes with risk of bladder cancer incidence and mortality in the Atherosclerosis Risk in Communities (ARIC) Study.

|Jun 12, 2026
Proteome Responses to Acute Inhibition of De Novo Sphingolipid Synthesis Suggest Cancer Combination Therapies.

|Jun 02, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

|Mar 27, 2026
Palmitate-induced mitochondrial damage restricts histone acetylation in CD8 T cells to impair antitumor immunity.

Silvia Tiberti, Sara Gennari, Martina Romeo

|Aug 07, 2025
Alzheimer's Disease-Associated Amyloid-β Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity.

Mohamed Faisal Kassir, Han Gyul Lee, Natalia V Oleinik

Pageof 5

Frequent Collaborators

7 joint publications

Mohamed Faisal Kassir

6 joint publications

Natalia V Oleinik

4 joint publications

Shikhar Mehrotra

3 joint publications

Alhaji H Janneh